Company Name

Industry

Location

Revenue

Employees

Avanir Pharmaceuticals

Pharmaceuticals

United States, California

$100M to $250M

501-1000

AMPAC Fine Chemicals

Pharmaceuticals

United States, California

$100M to $250M

501-1000

ANI Pharmaceuticals

Pharmaceuticals

United States, New Jersey

$100M to $250M

501-1000

APCER Life Sciences

Pharmaceuticals

United States, New Jersey

$100M to $250M

501-1000

Lovelace Biomedical

Pharmaceuticals

United States, New Mexico

$100M to $250M

501-1000

Advanced Diabetes Supply

Pharmaceuticals

United States, California

$100M to $250M

501-1000

MMS

Pharmaceuticals

United States, Michigan

$100M to $250M

501-1000

WIL Research

Pharmaceuticals

United States, Ohio

$100M to $250M

501-1000

Kyowa Kirin, Inc.- U.S.

Pharmaceuticals

United States, New Jersey

$100M to $250M

501-1000

Abzena

Pharmaceuticals

United States, California

$100M to $250M

501-1000

IntegriChain

Pharmaceuticals

United States, Pennsylvania

$100M to $250M

501-1000

Avara Pharmaceutical Services

Pharmaceuticals

United States, Oklahoma

$100M to $250M

501-1000

Excelya

Pharmaceuticals

United States, Minnesota

$100M to $250M

501-1000

TESARO

Pharmaceuticals

United States, Massachusetts

$100M to $250M

501-1000

Lupin Pharmaceuticals

Pharmaceuticals

United States, Maryland

$100M to $250M

501-1000

KCR

Pharmaceuticals

United States, Massachusetts

$100M to $250M

501-1000

Exela Pharma Sciences

Pharmaceuticals

United States, North Carolina

$100M to $250M

501-1000

URL Pharma

Pharmaceuticals

United States, Pennsylvania

$100M to $250M

501-1000

Mapi Group: Health Research & Commercialization

Pharmaceuticals

United States, Kentucky

$100M to $250M

501-1000

Red Nucleus

Pharmaceuticals

United States, Pennsylvania

$100M to $250M

501-1000